StonvexLoading…
StonvexStonvexStonvexCore line items from XENE's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Annual 2017 2017-12-31 | Q3 2017 2017-09-30 |
|---|---|---|
Revenue | $311.00K | $295.00K |
Operating Income | $-32.58M | $-24.52M |
Net Income | $-30.70M | $-22.64M |
EPS (Diluted) | $-1.72 | $-1.27 |
Total Assets | $46.12M | $46.36M |
Total Liabilities | $10.19M | $3.06M |
Cash & Equivalents | $20.49M | $14.69M |
Free Cash Flow OCF − CapEx | $-29.04M | $-22.14M |
Shares Outstanding | 18.00M | 18.00M |